Viewing nowCombinationTruEmpagliflozin 10/5 mg Tablet (Empagliflozin, Linagliptin)
Empagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.

MFDS item code 202502393 · Approved 2025.09.10
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication contains both empagliflozin and linagliptin, which help control blood sugar levels in patients with Type 2 diabetes. It is more effective when used in conjunction with diet and exercise, and it is used to maintain stable blood sugar levels.
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant therapy with empagliflozin and linagliptin should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older.
This medication contains two ingredients, empagliflozin and linagliptin, and is primarily used for the treatment of Type 2 diabetes. This medication should not be used in patients with allergies to empagliflozin or linagliptin, in patients with Type 1 diabetes, patients with diabetic ketoacidosis, and patients undergoing dialysis. Patients with decreased kidney function may experience reduced effectiveness, so kidney function should be regularly monitored, and caution is advised for patients with heart failure. Acute pancreatitis symptoms may occur; if severe abdominal pain persists, discontinue use immediately and consult a doctor. Additionally, bullous pemphigoid may occur, so if any skin abnormalities arise, discontinue use immediately and consult a specialist. The most commonly seen side effect while taking this medication is urinary tract infection; hypoglycemia, pancreatitis, and allergic reactions may occur rarely. Due to the risk of hypoglycemia, blood sugar levels should be closely monitored, especially when taken with insulin or sulfonylureas. This medication may cause dehydration or low blood pressure; therefore, caution is necessary for the elderly or patients with low blood pressure, and it is advisable to frequently monitor fluid status. The risk of urinary tract infections and genital fungal infections may increase, so if any infection symptoms arise, prompt treatment should be initiated. It is advisable to avoid this medication during pregnancy, and for breastfeeding mothers, it is recommended to discontinue breastfeeding as the medication may pass through breast milk. It is not recommended for children under the age of 18, as safety and efficacy have not been established. In case of overdose, seek medical attention immediately for appropriate treatment, as blood dialysis may not effectively remove the medication. This medication should be stored out of reach of children and kept in its original container to maintain its quality.
Urinary tract infection, vulvovaginitis, vulvitis, balanitis, other genital infections, hypersensitivity, angioedema, urticaria, hypoglycemia, thirst, ketoacidosis, cough, constipation, pancreatitis, oral ulcer formation, itching, rash, vesicular pemphigoid, rhabdomyolysis, blood volume depletion, increased urination, dysuria, interstitial nephritis, increased amylase, increased lipase, increased hematocrit, increased serum lipids, upper abdominal pain, enterocolitis, bowel obstruction, gastroenteritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disturbance, Alzheimer's dementia, chest pain, fever, facial swelling, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, abdominal pain, gastrointestinal disorders, irritable bowel syndrome, burning mouth syndrome, colitis, abdominal discomfort, dysphagia, gastric ulcer, gum bleeding, tooth loss, hemorrhoids, lower abdominal pain, diarrhea, vomiting, gastritis, gastrointestinal disorders, acute pyelonephritis, leukoderma, rhinitis, soft tissue infection, pharyngitis, Tsutsugamushi disease, periodontitis, tonsillitis, laryngitis, viral upper respiratory infection, decreased appetite, hypercholesterolemia, inadequate diabetes control, malnutrition, hyponatremia, headache, drowsiness, weakness, epistaxis, oropharyngeal pain, voice disorders, allergic rhinitis, wet cough, runny nose, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urinary albumin/creatinine ratio, positive urine leukocytes, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased creatine phosphokinase in blood, male pattern hair loss, excessive sweating, hair loss, dermatitis, anxiety, mood disorders, insomnia, depression, hypertension, hearing loss, vulvar pruritus, genital pruritus, dyslipidemia, obesity, hypoglycemia, secondary hyperaldosteronism, hyponatremia, dermal cyst, seborrheic dermatitis, atopic dermatitis, nummular eczema, heat rash, sebaceous gland hyperplasia, lumbar spinal canal stenosis, myalgia, limb pain, musculoskeletal chest pain, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, osteoarthritis, astigmatism, allergic conjunctivitis, blurry vision, corneal abrasion, macular fibrosis, conjunctival congestion, pathological myopia, retinal crystals, retinal vein occlusion, macular retinal detachment, eyelid edema, visual impairment, vitreous floaters, vitreous hemorrhage, epistaxis, exertional dyspnea, wet cough, residual sputum, skin laceration, rib fracture, iliotibial band syndrome, contusion, palpitations, arteriosclerosis, deep vein thrombosis, diabetic vascular complications, peripheral artery obstructive disease, insomnia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage helps preserve the drug's effectiveness and prevent deterioration.
Light yellow, round, biconvex film-coated tablet
30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Dongkoo Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Empagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Empagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.